USPTO serial 79319092
BIO DESIGN LAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 16, 2022
- Examiner
- JACKSON, SHA-KARA ELOUISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIO DESIGN LAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jong Park
Jong Park The PL Law Group, PLLC13800 Coppermine Rd., FL1-3Herndon, VA 20171UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; vaccines against flu; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical agents affecting digestive organs; stem cells for veterinary purposes; antibodies for veterinary purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; allergy medications; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; medicines for the treatment of gastrointestinal diseases; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; reagents for use in medical genetic testing; diagnostic preparations for medical purposes; human immune globulin; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells for medical purposes; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; anti-viral agents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 29, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 29, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 16, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 16, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 16, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 31, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 10, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 13, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 7, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 2, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |